Creating and Assessing a Voice Dataset for Automated Classification of Chronic Obstructive Pulmonary Disease

NCT ID: NCT05897944

Last Updated: 2025-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-16

Study Completion Date

2024-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This work aims to evaluate whether voice recordings collected from patients diagnosed with COPD and healthy control groups can be used to detect the disease using machine learning techniques.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Voice data and sociodemographic data on gender and age will be collected through the "VoiceDiganostic" application from the company Voice Diagnostic, which allows one to participate without location dependency. Participants with a diagnosis will be marked as the COPD group, and others will be marked as the healthy control group. Private information such as known comorbidities, personal security numbers, health parameters and communication information will be separately noticed in a participation table for each group.

The collected data will be transformed into mathematical vocal measures called voice features. A dataset consisting of voice features in conjunction with demographics and health data will be constructed for further usage as an input to ML techniques.

Descriptive statistical analysis will be held on attributes containing information on input data and gained outcomes from ML algorithms. The achieved results will be presented in the form of summary tables and graphs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COPD

Participants with clinically diagnosed Chronic obstructive pulmonary disease. Total 34 recruitment, 18 Female, 16 Male

COPD

Intervention Type OTHER

A data set consisting of information from COPD and HC groups will be used to experiment with the classification performance of several Machine Learning techniques.

HC

Participants without Chronic obstructive pulmonary disease diagnosis. Total 38 recruitment, 20 Female, 18 Male

COPD

Intervention Type OTHER

A data set consisting of information from COPD and HC groups will be used to experiment with the classification performance of several Machine Learning techniques.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

COPD

A data set consisting of information from COPD and HC groups will be used to experiment with the classification performance of several Machine Learning techniques.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* being 18 years old and older.

Exclusion Criteria

* being under 18 years old.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Excellence Center at Linköping - Lund in Information Technology (ELLIIT)

UNKNOWN

Sponsor Role collaborator

Blekinge Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Johan Sanmartin Berglund

Professor, MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johan Sanmartin Berglund, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Blekinge Institute of Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Blekinge Institute of Technology

Karlskrona, Blekinge County, Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Idrisoglu A, Dallora AL, Cheddad A, Anderberg P, Jakobsson A, Sanmartin Berglund J. COPDVD: Automated classification of chronic obstructive pulmonary disease on a new collected and evaluated voice dataset. Artif Intell Med. 2024 Oct;156:102953. doi: 10.1016/j.artmed.2024.102953. Epub 2024 Aug 15.

Reference Type DERIVED
PMID: 39222579 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BTH-6.1.1-0074-2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.